Xing Lv

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Venues

Nature communications

Journal of the National Cancer Institute

Journal of cancer research and clinical oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xun Cao, Hao-Yang Huang, Chi-Xiong Liang, Zhuo-Chen Lin, Jia-Yu Zhou, Xi Chen, Ying-Ying Huang, Ze-Jiang Zhan, Liang-Ru Ke, Lu-Jun Han, Wei-Xiong Xia, Lin-Quan Tang, Shan-Shan Guo, Hu Liang, Xiang Guo, Xing Lv
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial. Nature communications 15 (1) (2024)
Haoyang Huang, Yuping Zhao, Ying Deng, Zejiang Zhan, Yingying Huang, Xun Cao, Xi Chen, Jiayu Zhou, Chixiong Liang, Lulu Zhang, Zhuoying Luo, Xiang Guo, Xing Lv
Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study. International journal of cancer (2024)
Xun Cao, Hao-Yang Huang, Chi-Xiong Liang, Zhuo-Chen Lin, Jia-Yu Zhou, Xi Chen, Ying-Ying Huang, Ze-Jiang Zhan, Liang-Ru Ke, Lu-Jun Han, Wei-Xiong Xia, Lin-Quan Tang, Shan-Shan Guo, Hu Liang, Xiang Guo, Xing Lv
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial. Nature communications 15 (1) (2024)
Xun Cao, Hao-Yang Huang, Chi-Xiong Liang, Zhuo-Chen Lin, Jia-Yu Zhou, Xi Chen, Ying-Ying Huang, Ze-Jiang Zhan, Liang-Ru Ke, Lu-Jun Han, Wei-Xiong Xia, Lin-Quan Tang, Shan-Shan Guo, Hu Liang, Xiang Guo, Xing Lv
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial. Nature communications 15 (1) (2024)
Xun Cao, Hao-Yang Huang, Chi-Xiong Liang, Zhuo-Chen Lin, Jia-Yu Zhou, Xi Chen, Ying-Ying Huang, Ze-Jiang Zhan, Liang-Ru Ke, Lu-Jun Han, Wei-Xiong Xia, Lin-Quan Tang, Shan-Shan Guo, Hu Liang, Xiang Guo, Xing Lv
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial. Nature communications 15 (1) (2024)
Lu-Lu Zhang, Xi Chen, Ying-Ying Huang, Chi-Xiong Liang, Meng-Yun Qiang, Zhuo-Chen Cai, Ze-Jiang Zhan, Ying Deng, Jia-Yu Zhou, Hao-Yang Huang, Xiang Guo, Xing Lv
Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma. Cancer medicine (2023)
Mengyun Qiang, Chaofeng Li, Yuyao Sun, Ying Sun, Liangru Ke, Chuanmiao Xie, Tao Zhang, Yujian Zou, Wenze Qiu, Mingyong Gao, Yingxue Li, Xiang Li, Zejiang Zhan, Kuiyuan Liu, Xi Chen, Chixiong Liang, Qiuyan Chen, Haiqiang Mai, Guotong Xie, Xiang Guo, Xing Lv
A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma. Journal of the National Cancer Institute 113 (5) (2022)
Zhuochen Cai, Dongni Chen, Wenze Qiu, Chixiong Liang, Yingying Huang, Jiayu Zhou, Zejiang Zhan, Yanqun Xiang, Xiang Guo, Xing Lv
Concurrent chemoradiotherapy combined with nimotuzumab in stage III-IVa nasopharyngeal carcinoma: a retrospective analysis. Journal of cancer research and clinical oncology (2022)

Xing Lv.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xing Lv